Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2006
12/20/2006EP1622610B1 1-(2h-pyrazol-3-yl)-3-{4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/20/2006EP1523335B1 Injectable depot formulation comprising crystals of iloperidone
12/20/2006EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006CN1882580A Quinazoline derivatives as antiproliferative agents
12/20/2006CN1882578A 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
12/20/2006CN1882576A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006CN1882572A Quinazoline derivatives as antitumor agents
12/20/2006CN1882568A Pyrrol derivatives with antibacterial activity
12/20/2006CN1882565A Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (CCR-3)
12/20/2006CN1882553A Phenylacetic acid derivative, process for producing the same, and use
12/20/2006CN1882542A 2-pyridone derivatives as neutrophil elastase inhibitors and their use
12/20/2006CN1882337A Substituted oxadiazolidinediones ALS PAI-1 inhibitors
12/20/2006CN1882336A Substituted oxadiazolidinediones
12/19/2006US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006US7151113 Pyrazole-amine compounds useful as kinase inhibitors
12/19/2006US7151110 4-Methoxy-6-[3-(6-methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-quinoline; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents
12/19/2006US7151102 Phthalazinone derivatives
12/19/2006US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006US7151100 Indole compounds useful for the treatment of cancer
12/19/2006US7151098 Glutamate receptor antagonists
12/19/2006US7151075 Herbicides
12/19/2006CA2301872C 8a-azalides as veterinary antimicrobial agents
12/14/2006WO2006133326A1 Inhibitors of hcv replication
12/14/2006WO2006133242A2 Azinone and diazinone v3 inhibitors for depression and stress disorders
12/14/2006WO2006132295A1 Regulator of aldosterone receptor
12/14/2006WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY
12/14/2006WO2006132192A1 Novel 2-quinolone derivative
12/14/2006WO2006131452A1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS
12/14/2006WO2006131336A1 POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
12/14/2006WO2006131296A1 Substituted n-benzo [d] isoxazol-3-yl-amine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments
12/14/2006WO2006130986A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/14/2006WO2006116498A3 Purified form of tanaproget
12/14/2006WO2006107062A3 Benzimidazole derivative and use as angiotensin ii antagonist
12/14/2006WO2006089177A3 Isoxazole combretastin derivatives for the treatment of disorders
12/14/2006WO2006073589A3 Cycloalkyl keto piperidine tachykinin receptor antagonists
12/14/2006WO2006032466A3 New bicyclic antibiotics
12/14/2006WO2006000336A3 Anthranilamides serving as pesticides
12/14/2006US20060281795 Benzinidazole Derivative and Use As AII Receptor Antagonist
12/14/2006US20060281784 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/14/2006US20060281774 Pyrimidine derivatives for the treatment of abnormal cell growth
12/14/2006US20060281762 1,3-Benzoxazolyl derivatives as kinase inhibitors
12/14/2006US20060281747 1,2-di(cyclic) substituted benzene derivatives
12/14/2006US20060281746 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
12/14/2006US20060281744 e.g. 5-(4-tert-Butylbenzenesulfonylamino)-3-phenyl- 1 -benzothiophene-2-carboxylic acid-(2-hydroxypropyl)amide; contraceptive; for male fertility control; act on testicular stem cells and mature sperm
12/14/2006US20060281743 Isoquinolinone potassium channel inhibitors
12/14/2006US20060281741 Therapy for bacteria infections other than Myconacterium infections; antibiotic resistance
12/14/2006US20060281740 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamic acid, piperidinyl ester derivatives
12/14/2006US20060281736 Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
12/14/2006US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
12/14/2006US20060281728 3-Substituted beta-lactamyl vasopressin v1a antagonists
12/14/2006US20060281726 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
12/14/2006US20060281711 2-Morpholin-4-yl-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or immune-mediated diabetes mellitus
12/14/2006CA2610400A1 Azinone and diazinone v3 inhibitors for depression and stress disorders
12/14/2006CA2610373A1 Substituted n-benzo [d] isoxazol-3-ylamine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments
12/14/2006CA2610310A1 Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands
12/14/2006CA2610196A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/13/2006EP1731518A1 Cyclic amine compound and pest control agent
12/13/2006EP1731513A1 Phenoxyacetic acid derivative and medicine containing the same
12/13/2006EP1731512A1 Isoxazoline-substituted benzamide compound and noxious organism control agent
12/13/2006EP1731511A1 BicyclischeI heterocycles, medicaments containing these compounds, their use and methods for the production thereof
12/13/2006EP1731507A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
12/13/2006EP1730165A1 Inhibitors of hepatitis c virus ns3 protease
12/13/2006EP1730152A2 Tetrahydroquinoline derivatives and a process for preparing the same
12/13/2006EP1730141A1 Compounds for the treatment of diseases
12/13/2006EP1730136A1 N-piperidine derivates as ccr3 modulators
12/13/2006EP1730128A1 Anaplastic lymphoma kinase modulators and methods of use
12/13/2006EP1730125A2 Substituted hydroxyethylamine aspartyl protease inhibitors
12/13/2006EP1730122A2 Pyrimidine derivatives and methods of treatment related to the use thereof
12/13/2006EP1730121A2 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
12/13/2006EP1730118A1 Substituted azole derivatives, compositions, and methods of use
12/13/2006EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
12/13/2006EP1730112A1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
12/13/2006EP1729772A2 Heteroaryl piperidine glycine transporter inhibitors
12/13/2006EP1425014B1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
12/13/2006EP1392676B1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
12/13/2006CN1878771A Substituted bicyclic quinazolin-4-ylamine derivatives
12/13/2006CN1878767A Azole-based kinase inhibitors
12/13/2006CN1878766A Methods for synthesizing quinolinone compounds
12/13/2006CN1878762A Morpholine derivatives as norepinephrine reuptake inhibitors
12/13/2006CN1878759A Pyridazin-3 (2H) -one derivatives and their use as PDE4 inhibitors
12/13/2006CN1878552A Methods of use of thrombin receptor antagonists
12/13/2006CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
12/13/2006CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006CN1289486C Pyrimidine derivatives as regulating agent of insulin-like growth factor-1 receptor (igf-1)
12/13/2006CN1289483C Heterocyclic derivatives of glycinamide and its pharmaceutical uses
12/13/2006CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/12/2006US7148357 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
12/12/2006US7148249 Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
12/12/2006US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006US7148246 Therapy, prevention diseases of fatty acid metabolism, glucose utilization; insulin resistance; antidiabetic agents; antilipemic agents
12/12/2006US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006US7148219 Biaryl heterocyclic compounds and methods of making and using the same
12/12/2006US7148217 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
12/12/2006US7148029 Generating antibodies; quantitative analysis